KYORIN Pharmaceutical Co., Ltd.

TSE:4569 Stock Report

Market Cap: JP¥85.9b

KYORIN Pharmaceutical Future Growth

Future criteria checks 0/6

KYORIN Pharmaceutical's revenue and earnings are forecast to decline at 2.1% and 11.9% per annum respectively. EPS is expected to decline by 11.9% per annum. Return on equity is forecast to be 2.6% in 3 years.

Key information

-11.9%

Earnings growth rate

-11.9%

EPS growth rate

Pharmaceuticals earnings growth11.7%
Revenue growth rate-2.1%
Future return on equity2.6%
Analyst coverage

Low

Last updated31 Jul 2024

Recent future growth updates

Recent updates

KYORIN Pharmaceutical's (TSE:4569) Soft Earnings Are Actually Better Than They Appear

Nov 14
KYORIN Pharmaceutical's (TSE:4569) Soft Earnings Are Actually Better Than They Appear

Earnings and Revenue Growth Forecasts

TSE:4569 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2027119,3003,580N/A11,0401
3/31/2026124,6003,860N/A7,4301
3/31/2025124,6005,090N/A4,9491
9/30/2024119,7344,820-13,579-3,436N/A
6/30/2024120,0975,531N/AN/AN/A
3/31/2024119,5325,322-4,6971,549N/A
12/31/2023119,8304,260N/AN/AN/A
9/30/2023119,1145,238-2,6214,154N/A
6/30/2023116,5054,216N/AN/AN/A
3/31/2023113,2704,723-7,3972,008N/A
12/31/2022108,5245,826N/AN/AN/A
9/30/2022105,5255,053-1,5003,132N/A
6/30/2022105,4585,577N/AN/AN/A
3/31/2022105,5343,9323,6566,346N/A
12/31/2021105,6664,109N/AN/AN/A
9/30/2021104,2714,133-8903,321N/A
6/30/2021102,9104,059N/AN/AN/A
3/31/2021102,9046,130655,189N/A
12/31/2020106,3246,279N/AN/AN/A
9/30/2020109,4197,433-7184,387N/A
6/30/2020108,9236,478N/AN/AN/A
3/31/2020109,9836,1494,5227,739N/A
12/31/2019110,2176,131N/AN/AN/A
9/30/2019111,5595,4864,3627,695N/A
6/30/2019114,2387,072N/AN/AN/A
3/31/2019113,6206,869-4,029340N/A
12/31/2018109,7345,567N/AN/AN/A
9/30/2018110,2427,5516,58410,493N/A
6/30/2018109,3135,258N/AN/AN/A
3/31/2018110,6406,574N/A10,456N/A
12/31/2017111,4608,701N/AN/AN/A
9/30/2017111,5035,861N/A9,132N/A
6/30/2017114,1247,118N/AN/AN/A
3/31/2017115,3737,305N/A16,386N/A
12/31/2016116,8507,531N/AN/AN/A
9/30/2016121,72513,356N/A16,697N/A
6/30/2016120,62314,462N/AN/AN/A
3/31/2016119,48313,639N/A11,137N/A
12/31/2015118,98813,324N/AN/AN/A
9/30/2015114,39511,536N/A10,341N/A
6/30/2015113,29111,140N/AN/AN/A
3/31/2015113,12112,064N/A6,391N/A
12/31/2014111,57212,324N/AN/AN/A
9/30/2014111,66111,123N/A7,965N/A
6/30/2014111,55811,710N/AN/AN/A
3/31/2014111,40012,025N/A19,293N/A
12/31/2013111,23212,432N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4569's earnings are forecast to decline over the next 3 years (-11.9% per year).

Earnings vs Market: 4569's earnings are forecast to decline over the next 3 years (-11.9% per year).

High Growth Earnings: 4569's earnings are forecast to decline over the next 3 years.

Revenue vs Market: 4569's revenue is expected to decline over the next 3 years (-2.1% per year).

High Growth Revenue: 4569's revenue is forecast to decline over the next 3 years (-2.1% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4569's Return on Equity is forecast to be low in 3 years time (2.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y